Regen BioPharma Inc (RGBP) › Total LiabilitiesRegen BioPharma Inc (RGBP) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2013: $02014: $140.3K2015: $317.6K2016: $906.3K2017: $6.20M2018: $9.33M2019: $11.01M2020: $7.46M2021: $14.70M2022: $8.60M2023: $5.46M2024: $5.38M2025: $6.56M$6.56M2013Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$6.56M+21.9%2024$5.38M-1.5%2023$5.46M-36.5%2022$8.60M-41.5%2021$14.70M+97.1%2020$7.46M-32.2%2019$11.01M+18.0%2018$9.33M+50.6%2017$6.20M+583.6%2016$906.3K+185.3%2015$317.6K+126.4%2014$140.3K—2013$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share